Hancock Whitney Corp Raises Stock Position in Colgate-Palmolive (NYSE:CL)

Hancock Whitney Corp lifted its position in Colgate-Palmolive (NYSE:CLFree Report) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,118 shares of the company’s stock after acquiring an additional 277 shares during the period. Hancock Whitney Corp’s holdings in Colgate-Palmolive were worth $1,258,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. E Fund Management Hong Kong Co. Ltd. purchased a new stake in shares of Colgate-Palmolive during the second quarter valued at approximately $25,000. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $53,000. Finally, Prospera Private Wealth LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $64,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 1.3 %

Shares of NYSE CL opened at $96.59 on Wednesday. The firm’s 50-day moving average price is $97.74 and its 200-day moving average price is $98.59. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30. The stock has a market capitalization of $78.91 billion, a price-to-earnings ratio of 27.68, a P/E/G ratio of 3.39 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CL. TD Cowen cut their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Sanford C. Bernstein boosted their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. UBS Group upped their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $105.11.

Read Our Latest Stock Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.